Literature DB >> 18671331

Severe nontuberculous mycobacterial infection in 2 patients receiving rituximab for refractory myositis.

Joseph R Lutt, Mary L Pisculli, Michael E Weinblatt, Atul Deodhar, Kevin L Winthrop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18671331

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  14 in total

Review 1.  Does rituximab increase the incidence of infectious complications? A narrative review.

Authors:  Theodoros Kelesidis; George Daikos; Dimitrios Boumpas; Sotirios Tsiodras
Journal:  Int J Infect Dis       Date:  2010-11-11       Impact factor: 3.623

Review 2.  Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy.

Authors:  Kevin L Winthrop; Michael Iseman
Journal:  Nat Rev Rheumatol       Date:  2013-06-25       Impact factor: 20.543

Review 3.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 4.  Biologic therapy in the idiopathic inflammatory myopathies.

Authors:  Thomas Khoo; Vidya Limaye
Journal:  Rheumatol Int       Date:  2019-11-04       Impact factor: 2.631

Review 5.  Nontuberculous mycobacteria infections in immunosuppressed hosts.

Authors:  Emily Henkle; Kevin L Winthrop
Journal:  Clin Chest Med       Date:  2014-12-23       Impact factor: 2.878

Review 6.  [Anti-B-cell strategies in vasculitides and collagenoses].

Authors:  A Rubbert-Roth
Journal:  Z Rheumatol       Date:  2009-07       Impact factor: 1.372

7.  Syndrome of selective IgM deficiency with severe T cell deficiency associated with disseminated cutaneous mycobacterium avium intracellulaire infection.

Authors:  Asal Gharib; Ankmalika Gupta Louis; Sudhanshu Agrawal; Sudhir Gupta
Journal:  Am J Clin Exp Immunol       Date:  2015-10-12

8.  Systemic granulomatous reaction secondary to treatment of bladder cancer with bacillus calmette-guerin.

Authors:  Caterina Giovanna Valentini; Valentina Bozzoli; Anna Rita Larici; Luigi Maria Larocca; Giovanni Delogu; Giuseppe Leone; Livio Pagano
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-06-18       Impact factor: 2.576

9.  A Case of an Enigmatic Pulmonary Infiltrate.

Authors:  Uroosa Ibrahim; Amina Saqib; Michel Chalhoub; Jean Paul Atallah
Journal:  Cureus       Date:  2016-10-13

Review 10.  B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During Use.

Authors:  Md Yuzaiful Md Yusof; Edward M Vital; Maya H Buch
Journal:  Curr Rheumatol Rep       Date:  2015-10       Impact factor: 4.592
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.